anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

206,881-206,940 of 319,975

filter-aware
06
Uses two pie charts to illustrate growth over time.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
07
Includes footnotes defining active partners and active programs.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
08
The slide highlights social proof and market validation through a curated list of industry-leading partners.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
09
The chart shows a steady upward trend in clinical programs, with the final bar representing Q1 2023.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
10
OmniAb | Investor Presentation Deck | 39 slidesOmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
11
OmniAb | Investor Presentation Deck | 39 slidesOmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Interest1 hit
12
Uses a process-flow framework to map proprietary technologies to specific stages of the antibody discovery pipeline.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Interest1 hit
13
OmniAb | Investor Presentation Deck | 39 slidesOmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Interest1 hit
14
The slide uses a process-oriented header to show the platform's role in the drug discovery workflow.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Interest1 hit
15
The slide explains the genetic engineering approach of using human variable regions combined with rodent constant regions to facilitate immune response and subsequent conversion to fully human antibodies.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
16
The slide uses an evolutionary timeline to justify the technical superiority of the OmniChicken platform.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
17
Includes a scientific citation for the structural model.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
18
The slide illustrates how two different platforms (OmniFlic and OmniClic) converge on a single bispecific IgG format.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
19
The slide uses a process-oriented header to show where this step fits in the overall workflow.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
20
The slide uses a process diagram to contrast two distinct scientific workflows.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
21
The slide highlights the final stage of a three-part process: Identify the Right Antibody.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
22
The slide uses a process-flow framework to map proprietary technologies to specific stages of antibody discovery.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
23
The slide uses a three-row matrix structure to map biological sources to specific computational workflows.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Desire1 hit
24
The slide uses a screenshot of a conference presentation abstract as social proof/traction.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · DesireLoop · Quick Win Big Bet1 hit
25
The chart displays percentages for OmniRat (54%), Omniflic (26%), OmniChicken (14%), OmniClic (3%), and OmniMouse/OmniTaur (3% combined).OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
26
The slide uses a pie chart to categorize clinical molecules by modality and provides a gallery of specific molecular formats (Duobody, Fab-VHH, ADAPTIR, etc.) to illustrate diversity.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
The footer contains a dense list of specific patent application numbers as supporting evidence.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
28
OmniAb | Investor Presentation Deck | 39 slidesOmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
29
The slide uses a stacked bar/area hybrid chart to visualize deal economics over a 25-year horizon.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
30
Table includes rounded figures. Please reference press release dated 5/11/23 for more detailed information.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
31
The slide provides financial health context, specifically highlighting cash position and operational runway.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations 1 hit
32
The table highlights R&D and G&A expenses with an orange border.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations 1 hit
33
Table includes rounded figures. Please reference press release dated 3/30/23 for more detailed information.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations 1 hit
34
Provides a detailed view of the fully diluted share count.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations 1 hit
35
The slide is divided into two sections: Management (top) and Board of Directors (bottom). Matt Foehr appears in both sections.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations 1 hit
36
The slide uses a two-tier layout: top section for operational strategy and bottom section for stakeholder-centric values.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Action1 hit
37
OmniAb | Investor Presentation Deck | 39 slidesOmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Action1 hit
38
The slide uses a timeline framework to illustrate company growth and M&A activity.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Action1 hit
39
The slide uses a Gantt-style visualization to show the progression of drug candidates through clinical phases.OmniAb | Investor Presentation Deck | 39 slides · OmniAb
Pitch deck Investor relations Beat · Action1 hit
01
Slide 1
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What Is1 hit
02
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What Is1 hit
03
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What Is1 hit
04
The central circle acts as a focal point connecting the four quadrants of business strengths.OmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What Is1 hit
05
The chart shows a steady upward trend in the number of active partners, with a CAGR of 18% from 2016 to 2022.OmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
06
The bar chart shows growth from 2016 to 3/31/2023. The pie chart shows the distribution of the 301 active programs.OmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
07
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
08
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
09
Slide 9 of a presentation deck.OmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What Could BeLoop · So What Cascade1 hit
10
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · What Could BeLoop · So What Cascade1 hit
11
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · New Bliss1 hit
12
The table includes a variance column and EPS data.OmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · New Bliss1 hit
13
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · New Bliss1 hit
14
The table highlights R&D and G&A expenses with an orange box.OmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · New Bliss1 hit
15
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · New Bliss1 hit
16
OmniAb | Results Presentation Deck | 17 slidesOmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · New Bliss1 hit
17
The table uses color-coded bars to indicate clinical phase progress (Phase 1, 2, 3, Registration, Approved).OmniAb | Results Presentation Deck | 17 slides · OmniAb
Conference presentation Investor relations Beat · New Bliss1 hit
01
Slide 1
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
02
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
03
The slide uses a dark green background with light green geometric shapes and two circular-cropped images showing clinicians and automated pharmacy equipment.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · Key Messages1 hit
04
The diagram uses a circular process flow (Assess, Prescribe, Dispense, Administer) surrounding a central platform concept.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · Key Messages1 hit
05
The slide uses a numbered list format to present strategic pillars.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · Key Messages1 hit
06
The slide uses a maturity model to visualize the progression of pharmacy automation.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · Propose Solution1 hit
07
The slide uses a hub-and-spoke style diagram to map service offerings to care settings.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit
08
The chart uses a central donut hole to emphasize the total TAM figure.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations Beat · Market Sizing1 hit
09
Omnicell | Investor Presentation Deck | 27 slidesOmnicell | Investor Presentation Deck | 27 slides · Omnicell
Conference presentation Investor relations 1 hit